Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHow the Wegovy tablet works, who it's for, and how to get it safely
Is the Wegovy pill the same medicine as the injection?
The active ingredient is identical: semaglutide, made by Novo Nordisk. What changes is the delivery. The injection puts semaglutide under the skin once a week; the tablet carries it into the body through the gut, helped by an absorption enhancer called SNAC that protects the molecule long enough to be taken up from the stomach.
That difference in route is why the two products aren't interchangeable dose-for-dose. A tablet has to survive digestion, so the milligram numbers on the pill schedule look nothing like the weekly injection figures. The end goal is the same, though: semaglutide acts on the GLP-1 receptor to reduce appetite and slow how quickly the stomach empties, so many people feel full sooner and for longer.
Novo Nordisk designed the tablet for people who would rather not use a needle, or who find weekly injections awkward to fit around life. If you've been reading up on oral semaglutide for weight loss, that's the same medicine under discussion. Both forms carry the Black Triangle symbol, which flags that the MHRA is collecting extra monitoring data.
One thing worth being clear on early: this is the weight-management tablet, not the diabetes one. Rybelsus is also oral semaglutide, but it's licensed for type 2 diabetes at different strengths, and the two shouldn't be confused.
How do you actually take the Wegovy tablet each day?
The routine matters more with the tablet than the injection, because food and drink interfere with how much semaglutide gets absorbed. It's taken once daily, first thing in the morning, on an empty stomach, with no more than a small sip of plain water. You then wait at least 30 minutes before eating, drinking anything else (yes, that includes coffee) or taking other oral medicines. The tablet is swallowed whole, not crushed or split.
A quick habit that helps: keep the pack somewhere you'll see it before the kettle goes on, so the tablet is taken and the 30-minute clock has started before breakfast even begins. That small bit of timing is the difference between the dose working as intended and being partly wasted.
Storage is genuinely easier than the injection. There's no refrigeration, so it lives at room temperature and packs into a bag without a cool bag or ice pack. For anyone who found the fridge logistics of the weekly pen a hassle, that's a real practical win.
We won't set out a personal dosing plan here, because that's a decision for the prescriber and the Patient Information Leaflet, not a web page. What we can say is that the licensed schedule builds up in steps over several months rather than starting at full strength, which is deliberate and helps the body adjust.
What's the dose schedule for the Wegovy weight-loss tablet?
The licensed schedule for the weight-management tablet climbs through four levels: it begins at 1.5mg once daily, then moves to 4mg, then 9mg, and finally settles at the 25mg maintenance dose. Each step lasts a minimum of one month before the next increase, which gives the digestive system time to settle at each level.
People already established on the 2.4mg weekly Wegovy injection may be able to move directly to the 25mg tablet, but only after a clinical assessment confirms it's appropriate. That's a prescriber's call, not something to arrange yourself, and the timing of any switch is checked case by case.
A common point of confusion is worth heading off. The 3mg, 7mg and 14mg tablet strengths belong to Rybelsus, the diabetes version of oral semaglutide. They are not rungs on the Wegovy weight-loss ladder and shouldn't be treated as such. If you've seen those numbers quoted, they relate to a different licence entirely.
Because the schedule is gradual, the first pack does a different job to the last. The early doses exist mainly to let your body get used to the medicine and keep side effects manageable, rather than to drive the bulk of any weight change. The exact timings, and what happens if a day is missed, live in the SmPC and leaflet and should be followed as your prescriber directs.
Who is the Wegovy tablet licensed for?
The tablet is licensed for adults with a BMI of 30 or above, or between 27 and 29.9 if you also have a weight-related health condition, taken alongside a reduced-calorie diet and more physical activity. Weight-related conditions include things like high blood pressure, high cholesterol, prediabetes, type 2 diabetes, obstructive sleep apnoea and osteoarthritis.
If you want to check where you sit before anything else, the fastest move is a minute with the NHS calculator. The NHS BMI calculator gives you the number the licence talks about in about sixty seconds. Under UK guidance, thresholds can be set 2.5 kg/m² lower for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, reflecting differences in health risk at a given BMI.
Meeting the BMI figure is the start of the conversation, not the whole of it. A prescriber looks at your full history, current medicines, and anything that would make the medicine unsuitable before deciding. It isn't recommended for anyone under 18, and it isn't suitable if you're pregnant, breastfeeding or trying to conceive.
If the tablet turns out not to be right for you, the injection remains an option for many people, and our weight-loss treatment options lay out what's available through our pharmacy. The right form is a clinical fit, not a personal preference alone.
How well does the Wegovy pill work?
The evidence comes from the OASIS 4 trial, a phase 3 study of 307 adults with obesity or overweight plus at least one weight-related condition, none of whom had diabetes, run over 64 weeks alongside lifestyle changes. Participants taking the oral semaglutide lost around 13.6% of their body weight on average, compared with roughly 2.4% on placebo.
Among the people who stayed fully adherent to treatment throughout the trial, the average was higher, at about 17%, against roughly 2.7% for placebo. It's worth being precise about that second figure: it reflects those who kept to the treatment as prescribed, not the headline average everyone should expect, so 13.6% is the more honest number to plan around.
Those results put the tablet in a similar territory to the injection for many people, though individual outcomes vary and no medicine guarantees a result. The trial paper is the primary source here; for a plain-English overview of how these medicines fit into weight management, the NHS page on semaglutide is a good starting point.
Weight change also depends on what happens around the medicine. The tablet is licensed to be used with a reduced-calorie diet and more activity, and it works best when those pieces are in place. If you'd like the wider picture of how treatment sits alongside everyday changes, our guide to weight-loss treatment covers it.
What are the side effects of oral semaglutide?
The most common effects are gastrointestinal. In OASIS 4, side effects of that kind affected 74% of people on oral semaglutide versus 42.2% on placebo, and they were generally mild to moderate and tended to ease over time. In practice that means nausea, an unsettled stomach, changes to how you go to the loo, reflux, and sometimes tiredness or headache, most noticeable when starting or stepping up a dose.
There's a less common but serious effect to know about. In January 2026 the MHRA issued a safety update flagging acute pancreatitis as an infrequent risk with GLP-1 medicines. The sign to act on is severe, persistent stomach pain that may spread through to your back, sometimes with vomiting; if that happens, get urgent medical help rather than waiting to see if it settles.
Anyone can report a suspected side effect through the MHRA Yellow Card scheme, which is also how the regulator keeps building its safety picture. It takes a couple of minutes and helps everyone.
Because the tablet relies on that empty-stomach routine, getting the timing wrong won't harm you, but it can blunt how well it works. If side effects are making the routine hard to keep, that's exactly the sort of thing to raise with a prescriber, who can talk through options rather than leaving you to guess.
Is the Wegovy tablet available on the NHS, and how do you get it privately?
Not yet on the NHS. A new medicine needs a NICE appraisal before the NHS can routinely fund it, and at launch the Wegovy tablet is available on private prescription only. That's a normal position for a newly approved treatment, not a red flag.
The legal route is the same as for the injection: a prescription following a proper clinical assessment, from a pharmacy you can check. At nume, that means a free consultation reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reading your answers rather than software waving you through. You can confirm any online pharmacy is genuine on the GPhC register before you buy anything, and it's a habit worth keeping.
Steer clear of anywhere offering semaglutide without a clinical assessment, social-media sellers, or prices far below the market. The MHRA has warned repeatedly about fake weight-loss pens, and legitimate supply always runs through a registered pharmacy and the licensed UK supply chain. The people behind our pharmacy are set out on our clinical team page if you'd like to see who reviews these consultations.
If you're not sure whether the tablet or the injection fits you better, that's precisely what the consultation is for. Check your eligibility with our prescribers, and if the tablet suits you, they'll say so. If it doesn't, they'll tell you that too.
Related questions we've answered
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.